Feed RXRX
RX
Recursion Pharmaceuticals
RXRX · NASDAQ
$3.16 -4.24% (-$0.14)
1M +4.64%
Market Cap $1.7B
P/E Ratio -
Div. Yield -
ROE 65.71%
Valuation
50 /100
Fair P/S 23.25x
P/B 1.54x
P/E N/A
Growth
100 /100
Growing Rev. growth 23.46%
Book val. growth 32.53%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 61.96%
Net margin 863.35%
Op. margin 867.87%
Quality
1 /100
Poor ROIC 48.06%
ROE 65.71%
ROA 43.74%
Debt
69 /100
Low Debt/Equity 0.07x
Current ratio 5.50x
Int. coverage -355.30x
Stability
77 /100
Stable Beta 1.00x
Rev. volatility 12.06%
EPS volatility 15.90%
Întreabă StockBot despre RXRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Najat Khan
Employees
600
Headquarters
Salt Lake City
Evenimente viitoare
04 NOV.
Earnings
Upcoming earnings report